Skip to content
Screener

EBITDA at other companies

Pfizer logo
PfizerPFE
$4.78B+8.6%
Amgen logo
AmgenAMGN
$4.63B+15.7%
AbbVie logo
AbbVieABBV
$5.93B+2.7%
Opko Health logo
Opko HealthOPK
$15.44M+142%
Viatris logo
ViatrisVTRS
$678.6M-25.5%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.56B+57.0%
Enterprise value$11.01B+4.2%
P/E6.6×+2.1×
P/S0.6×+0.2×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

$324.0Mebit+
$39.0MDepreciation Depletion & Amortization
=$363M

The source filing: Organon’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 8:46 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-029532

FAQ

What is Organon's EBITDA?
Organon (OGN) reported EBITDA of $363M in Q1 2026.
How has Organon's EBITDA changed year-over-year?
Organon's EBITDA increased by 40.2% year-over-year, from $259M to $363M.
What is the long-term trend for Organon's EBITDA?
Over 3 years (2021 to 2024), Organon's EBITDA has grown at a -8.1% compound annual growth rate (CAGR), from $1.88B to $1.46B.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Organon's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude